Welcome to our dedicated page for Ventas news (Ticker: VTR), a resource for investors and traders seeking the latest updates and insights on Ventas stock.
Ventas, Inc. (VTR) is a leading healthcare real estate investment trust (REIT) specializing in senior housing communities, medical offices, and life science facilities. This page serves as the definitive source for official company announcements and market-moving developments.
Investors and industry professionals will find timely updates including quarterly earnings reports, property portfolio expansions, and strategic partnerships. Our curated news collection provides essential insights into operational milestones across Ventas' diversified healthcare assets.
Key coverage areas include senior housing market trends, medical office lease agreements, and research facility developments. All content is verified through primary sources to ensure accuracy and compliance with financial disclosure standards.
Bookmark this page for streamlined access to Ventas' latest press releases and sector analysis. Regularly updated to reflect new developments impacting this healthcare REIT's market position.
Ventas, Inc. (NYSE: VTR) has announced that its subsidiary, Ventas Realty, Partnership, has priced a $550 million public offering of 5.000% Senior Notes due 2035. The notes, priced at 99.647% of the principal amount, will be senior unsecured obligations guaranteed by Ventas. The offering is expected to close on September 9, 2024, subject to customary conditions.
Ventas intends to use the proceeds for general corporate purposes, including potential repayment of other debts like the 2.650% Senior Notes due 2025. Wells Fargo Securities, MUFG Securities Americas, PNC Capital Markets, and Truist Securities are acting as joint book-running managers for the offering.
Ventas (NYSE: VTR) reported strong Q2 2024 results, driven by robust performance in its senior housing operating portfolio (SHOP). Key highlights include:
- Normalized FFO per share of $0.80, up 7% year-over-year
- Total Company NOI growth of 6.9% year-over-year
- SHOP Same-Store Cash NOI growth of 15.2% year-over-year
- SHOP occupancy growth of 320 basis points year-over-year
Ventas closed approximately $350 million in senior housing investments year-to-date, with a pipeline of additional opportunities. The company issued 10.4 million shares, raising about $500 million to fund these investments. Ventas improved its financial strength, with Net Debt-to-Further Adjusted EBITDA at 6.4x, down 0.5x from year-end 2023. The company has updated and improved its full-year 2024 guidance based on these strong results.
Ventas, Inc. (NYSE: VTR) has announced the release date for its second quarter 2024 earnings. The company will issue its earnings report after the close of trading on the New York Stock Exchange on Thursday, August 1, 2024. A conference call to discuss the results is scheduled for Friday, August 2, 2024, at 10:00 a.m. Eastern Time.
Investors can participate in the conference call by dialing (888) 330-3576 (or +1 (646) 960-0672 for international callers) with the participant passcode 7655497. A live webcast will be available on the company's website. Ventas is a leading S&P 500 real estate investment trust focused on senior housing communities, outpatient medical buildings, research centers, and healthcare facilities.
Ventas (NYSE: VTR) announced that its management will present at Nareit's REITweek 2024 Investor Conference on June 4, 2024, at 2:15 p.m. ET. The webcast and accompanying materials will be accessible on Ventas' website. Ventas, an S&P 500 real estate investment trust, focuses on senior housing communities and other healthcare facilities in North America and the UK. The company aims to deliver strong shareholder returns through operational expertise and data-driven insights from its Ventas Operational Insights platform. Ventas manages approximately 1,400 properties and emphasizes excellence and integrity in its operations.
Ventas, a leading S&P 500 real estate investment trust (REIT), has released a business update. The company focuses on senior housing communities, outpatient medical buildings, research centers, and healthcare facilities in North America and the UK. Ventas aims to deliver sustainable shareholder returns through operational expertise, data-driven insights, and strong financial positioning. The update materials are available on Ventas' website and will be archived for a time.
Ventas (NYSE: VTR) announced a quarterly dividend of $0.45 per common share for Q2 2024.
This dividend will be paid to shareholders on July 18, 2024, with a record date of July 1, 2024.
Ventas is a leading S&P 500 real estate investment trust (REIT) specializing in senior housing, outpatient medical buildings, research centers, and healthcare facilities across North America and the UK.
The company aims to deliver strong, sustainable shareholder returns by leveraging its operational expertise, data-driven insights, and extensive industry relationships.
With a portfolio of approximately 1,400 properties, Ventas is dedicated to enhancing the living conditions of the aging population.
Ventas, Inc. announced the pricing of $500 million aggregate principal amount of 5.625% Senior Notes due 2034. The Notes will be fully and unconditionally guaranteed by the Company and mature on July 1, 2034. The proceeds will be used for general corporate purposes, including repayment of other indebtedness.
Ventas, Inc. (NYSE: VTR) will participate in investor meetings at the BMO 2024 Real Estate Conference on May 8, 2024. Ventas is a leading S&P 500 real estate investment trust focused on providing exceptional environments for the aging population through senior housing communities and healthcare facilities across North America and the United Kingdom.
Ventas, Inc. (NYSE: VTR) reported positive first quarter 2024 results with a Net Loss per share of ($0.04), Normalized FFO per share of $0.78 (+5% YoY) and Total Company NOI growth of 8.2%. The company experienced strong demand in senior housing, leading to accelerated occupancy growth and improved guidance for the full year.
FAQ
What is the current stock price of Ventas (VTR)?
What is the market cap of Ventas (VTR)?
